Rongta Tech faces HKEX resumption guidance; share trading remains halted since 1 April 2026

Bulletin Express
04/27

Rongta Technology (Xiamen) Group Co., Ltd. (Rongta Tech) has received a formal resumption roadmap from The Stock Exchange of Hong Kong after trading in its H-shares was suspended on 1 April 2026 due to delayed publication of FY2025 results.

Key directives from HKEX, issued on 24 April 2026, require Rongta Tech to:

• Complete an independent forensic investigation into transactions linked to the audit issues, disclose findings, and implement remedial measures. • Verify that management integrity, competence and character satisfy regulatory expectations. • Engage an independent consultant to review and rectify internal‐control deficiencies, and demonstrate that the control environment enables full Listing Rule compliance—particularly in financial reporting and related-party transactions. • Publish all outstanding financial statements and resolve any audit qualifications. • Prove ongoing compliance with Listing Rule 13.24 regarding sufficient operations or assets. • Release all material information needed for investors to assess the company’s position.

Timeline pressure is significant. Under Listing Rule 6.01A(1), HKEX may cancel Rongta Tech’s listing if suspension exceeds 18 months; the deadline falls on 30 September 2027. The exchange retains the discretion to impose a shorter remedial period.

Operationally, Yue Xiu Capital Limited—appointed on 10 June 2025 as the company’s compliance adviser—must be proactively involved throughout the remediation process. In addition, Rongta Tech must issue quarterly progress updates; the first is due by 30 June 2026.

Share trading will remain frozen until audited FY2025 results are released. The board, chaired by Mr. Xu Kaiming, advises shareholders and prospective investors to exercise caution while the suspension persists.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10